Flexible Supply Strategies for Complex Clinical Trials
Summary: As clinical trials grow increasingly decentralised and patient-centric, traditional clinical supply chains often fall short. This shift is driven by the increasing complexity of therapies, the need for faster market entry, and a focus on sustainability. This executive summary evaluates clinical supply models and introduces FastChain? our demand-led decentralized model that aligns supply with real-time patient needs. By leveraging integrated approaches we can optimize drug use, support adaptive trial designs, and incorporate specialized case management for advanced therapy medicinal products (ATMPs).